Cargando…
A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
The non-muscle invasive bladder cancer tends to recur and progress. Therefore, it requires frequent follow-ups, generating costs and making it one of the most expensive neoplasms. Considering the expensive and invasive character of the current gold-standard diagnostic procedure, white-light cystosco...
Autores principales: | Matuszczak, Milena, Kiljańczyk, Adam, Salagierski, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369188/ https://www.ncbi.nlm.nih.gov/pubmed/35955727 http://dx.doi.org/10.3390/ijms23158597 |
Ejemplares similares
-
Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review
por: Matuszczak, Milena, et al.
Publicado: (2023) -
The Role of Focal Therapy and Active Surveillance for Small Renal Mass Therapy
por: Matuszczak, Milena, et al.
Publicado: (2022) -
Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021) -
Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
por: Matuszczak, Milena, et al.
Publicado: (2020) -
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
por: Lodewijk, Iris, et al.
Publicado: (2018)